EC-Cap-SC: Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy

Sponsor
Helios Albert-Schweitzer-Klinik Northeim (Other)
Overall Status
Completed
CT.gov ID
NCT02331836
Collaborator
(none)
561
6
3
48
93.5
1.9

Study Details

Study Description

Brief Summary

Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)

Condition or Disease Intervention/Treatment Phase
  • Device: Arc Endocuff (AEC 110, 120, 130, 140)
  • Device: Cap
  • Device: Standard colonoscope
N/A

Detailed Description

The Endocuff is a medical device, approved in 2012 by the American Food and Drug Administration, which was also authorized by the European Agency for the Evaluation of Medicinal Products. The aim of the cuff is to optimize the view of the colonic mucosa. There is also a transparent cap on the market, which is used in colonoscopy for a better evaluation of the mucosa and polyp detection. The goal of this project is to conduct a prospective randomized trial for clarification of the hypotheses, whether the usage of the Endocuff increases the detection rate of adenomas compared to the transparent cap or compared to standard colonoscopy.

Study Design

Study Type:
Interventional
Actual Enrollment :
561 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Diagnostic
Official Title:
Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy for Adenoma Detection: A Randomized Controlled European Multicenter Study
Actual Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Feb 1, 2019
Actual Study Completion Date :
Feb 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arc Endocuff (AEC 110, 120, 130, 140)

Endocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope

Device: Arc Endocuff (AEC 110, 120, 130, 140)

Active Comparator: Cap

Cap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope

Device: Cap
Olympus Disposable distal attachment 15mm diameter, 4mm depth

Active Comparator: Standard Colonoscope

Standard colonoscopy without any additional device

Device: Standard colonoscope

Outcome Measures

Primary Outcome Measures

  1. Adenoma detection rate [1 year]

    Proportion of patients having at least one adenoma

  2. Polyp detection rate [1 year]

    Proportion of patients having at least one adenoma

Secondary Outcome Measures

  1. Bowel preparation result [one day]

  2. Coecum intubation rate [one year]

  3. Ileum intubation rate [one year]

  4. Coecum intubation time [one day]

  5. withdrawal time [one day]

  6. mucosal laceration [one day]

  7. severe bleeding [one day]

  8. perforation [one day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Colonoscopy independent from indication

  • Age ≥ 18

  • Patient is able to provide informed consent for the procedure

Exclusion Criteria:
  • Inflammatory Bowel Disease stenosis

  • Pregnant of nursing patient

  • Acute diverticulitis

  • Active Inflammatory Bowel Disease

  • Age ≤ 18

  • Coagulation disorder (INR>1.4 , Thrombocytes < 50000/µl)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Muenster Muenster North-Rhine Westphalia Germany 48149
2 University Medical Center Göttingen Göttingen Germany 37075
3 HELIOS St. Marienberg Klinik Helmstedt Helmstedt Germany
4 HELIOS Albert-Schweitzer-Klinik Northeim Germany 37154
5 HELIOS Medical Center Siegburg Siegburg Germany
6 Wroclaw Medical University Wroclaw Poland 50-556

Sponsors and Collaborators

  • Helios Albert-Schweitzer-Klinik Northeim

Investigators

  • Principal Investigator: Tobias Meister, Prof. Dr.med., Helios Albert-Schweitzer-Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tobias Meister, Prof. Dr. med. Tobias Meister, Helios Albert-Schweitzer-Klinik Northeim
ClinicalTrials.gov Identifier:
NCT02331836
Other Study ID Numbers:
  • EC-CUFF-2015
First Posted:
Jan 6, 2015
Last Update Posted:
Feb 12, 2019
Last Verified:
Feb 1, 2019
Keywords provided by Tobias Meister, Prof. Dr. med. Tobias Meister, Helios Albert-Schweitzer-Klinik Northeim
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 12, 2019